Copyright
©The Author(s) 2016.
World J Gastroenterol. Jan 7, 2016; 22(1): 417-426
Published online Jan 7, 2016. doi: 10.3748/wjg.v22.i1.417
Published online Jan 7, 2016. doi: 10.3748/wjg.v22.i1.417
NMR | MS | |
Sensitivity (detection limit) | Usually micromolar (nanomolar with cryosonde) | Picomolar |
Reproducibility | High | Low |
Detected | Non targeted approach | Targeted approach |
Metabolite | Detect metabolite Only if contain proton on the molecule | Need specific preparation to well detected some metabolites (Lipids…) |
Metabolite identification | Easy, using 1D and/or 2D spectra and databases | More difficult, need sometime complementary analysis |
Number of know identifiable metabolites | More than 200 | More than 4000 |
Sample | Simple preparation (minimal add of D2O, Buffer and sometime reference) | Preparation more complex (protein extraction, etc.) |
Non destructive method | Destructive method | |
Need 400 μL (less than 10 μL with microprobe) | Need few microliters | |
Type of sample | Liquid (urine, whole blood, serum, plasma, etc.) and intact tissue | Liquid |
Cost of machine | Very high | High |
Cost of sample analysis | Lower | Higher |
Signal acquisition time | 5 to 15 min for 1D spectra | Around 10 min |
More longer for 2D spectra (few hours) |
- Citation: Amathieu R, Triba MN, Goossens C, Bouchemal N, Nahon P, Savarin P, Le Moyec L. Nuclear magnetic resonance based metabolomics and liver diseases: Recent advances and future clinical applications. World J Gastroenterol 2016; 22(1): 417-426
- URL: https://www.wjgnet.com/1007-9327/full/v22/i1/417.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i1.417